miRoncol is developing an innovative technology to screen 12+ solid tumor cancers in one blood test. Based on microRNA (miRNA), it is highly accurate, highly affordable, and highly accessible using widely available PCR equipment. Enabled by breakthrough technology, miRoncol aims to democratize access to early cancer detection and save lives from cancer.
View Top Employees from miRoncol DiagnosticsWebsite | https://www.mironcol.com |
Employees | 4 (0 on RocketReach) |
Founded | 2022 |
Address | 601 Walnut St # 715, Philadelphia, Pennsylvania 19106, US |
Industry | Medical and Diagnostic Laboratories |
Looking for a particular miRoncol Diagnostics employee's phone or email?
miRoncol Diagnostics is based in Philadelphia, Pennsylvania.